CTRI Number |
CTRI/2020/03/023785 [Registered on: 05/03/2020] Trial Registered Prospectively |
Last Modified On: |
03/03/2020 |
Post Graduate Thesis |
Yes |
Type of Trial |
Observational |
Type of Study
|
Cross Sectional Study |
Study Design |
Single Arm Study |
Public Title of Study
|
Correlating patients symptoms and findings on upper gastrointestinal endoscopy with the presence of H. pylori infection
Additional genetic testing of the sample for detection of H.pylori species
|
Scientific Title of Study
|
Correlation of patient symptomatology and gastric mucosal findings on upper gastrointestinal scopy
with detection of helicobacter pylori on histopathological examination and genotyping of the helicobacter pylori species. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Janani Seshasayee |
Designation |
Junior resident |
Affiliation |
Kasturba medical college and hospital (MAHE) |
Address |
Department of General Surgery
Kasturba medical college and hospital (MAHE)
Udupi KARNATAKA 576104 India |
Phone |
9962488858 |
Fax |
|
Email |
janani111194@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr K Veena L Karanth |
Designation |
Professor |
Affiliation |
Kasturba medical college and hospital (MAHE) |
Address |
Department of General Surgery
Kasturba medical college and hospital (MAHE)
Udupi KARNATAKA 576104 India |
Phone |
9845417715 |
Fax |
|
Email |
karanthkvl@yahoo.co.in |
|
Details of Contact Person Public Query
|
Name |
Dr Janani Seshasayee |
Designation |
Junior resident |
Affiliation |
Kasturba medical college and hospital (MAHE) |
Address |
Department of General Surgery
Kasturba medical college and hospital (MAHE)
Udupi KARNATAKA 576104 India |
Phone |
9962488858 |
Fax |
|
Email |
janani111194@gmail.com |
|
Source of Monetary or Material Support
|
Department of General surgery, Kasturba medical college and hospital(MAHE), Manipal 576104, Karnataka |
|
Primary Sponsor
|
Name |
Dr Janani Seshasayee |
Address |
Department of General Surgery
Kasturba medical college and hospital (MAHE) |
Type of Sponsor |
Other [SELF] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Janani Seshasayee |
CHARAKA SCOPY ROOM |
BALLIGA BLOCK, 4TH FLOOR
KASTURBA MEDICAL COLLEGE AND HOSPITAL (MAHE)
MANIPAL 576104
KARNATAKA Udupi KARNATAKA |
9962488858
janani111194@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Kasturba medical college and Kasturba hospital Institutional Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: K296||Other gastritis, |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
90.00 Year(s) |
Gender |
Both |
Details |
Patients undergoing UGI scopy, consenting for filling the questionnaire |
|
ExclusionCriteria |
|
Method of Generating Random Sequence
|
|
Method of Concealment
|
|
Blinding/Masking
|
|
Primary Outcome
|
Outcome |
TimePoints |
To help detect more cases of H.pylori based on UGI scopy mucosal findings
enabling earlier diagnosis and prompting stringent need for multiple gastric biopsies.
|
1 year 6 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
To identify prevalence of H.pylori in patients on UGI scopy for
enhancing management techniques for eradication of H.pylori.
To help in recording the risk factors
To provide a diagnostic tool for the detection of infection as well as guidance for treatment decisions.  Â
Genotyping of H.pylori prevalence in our population |
1 year 6 months |
|
Target Sample Size
|
Total Sample Size="385" Sample Size from India="385"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
09/03/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="7" Days="15" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This is a prospective observational study titled correlation of patient symptomatology and gastric mucosal findings on upper gastrointestinal scopy with detection of H.Pylori on histopathological examination and genotyping of the H.pylori species.
The prime objectives of this study include the following: 1. To identify the gastric mucosal findings on endoscopy associated with H.pylori positive biopsy specimens 2. To study the correlation of H.pylori associated gastritis in patients with upper GI symptoms. 3. To identify the risk factors for H.pylori positivity in patients with upper GI symptoms. 4. To study the genotypes of H.pylori prevalent in our population
The procedure of the study is as follows: 1. Consent is taken before recruitment of patient. During endoscopy, left over biopsy samples will be taken, will be stored in Bouin’s fluid and sent for genomic study. The procedure may take an additional 5-10 minutes. There will be no benefits or risks to the patient. 2. Pre determined questionnaire is administered to the patient. 3. Photographs are taken as per the proforma for mucosal patterns in addition to those taken during a routine UGI scopy procedure. 4. Histopathologic report is retrieved for analysis. 5. Method for Genetic study: An endoscopy-based biopsy and polymerase chain reaction (PCR) testing on gastric biopsies to diagnose the bacterium in 20 samples. DNA would be isolated from the tissue samples nested PCR would be performed with H pylori specific sequence of 16s ribosomal RNA gene for detection and then confirmed with PCR for urease gene (ureA) specific to H pylori. Conventional PCRs will be performed for determination of the virulence genes vacA and cagA PAI for samples positive for H. pylori-specific 16s and ureA genes, using primer designed for them 6. Longterm studies: If feasible, 385 samples will be collected for DNA/and RNA isolation for future validation/estimation of bacterial loads and occurrence of different virulence factors and mutations associated with resistance to antimicrobial agents. Host DNA could be analysed for factors predisposing to susceptibility to infection. Phylogenetic analysis would also be performed after DNA sequencing of the 16s ribosomal RNA gene segments from the H. pylori strains, also using sequences available in the public domain with NCBI-BLAST server and Clustal W program.
The expected outcome measures for the study include the following: ï‚· The study will help to detect more cases of H.pylori based on UGI scopy mucosal findings enabling earlier diagnosis and prompting a stringent need for multiple gastric biopsies. ï‚· The study will identify the prevalence of H.pylori in patients on UGI scopy providing data on enhancing management techniques for eradication of H.pylori. ï‚· The questionnaire will also help in recording the risk factors and tabulate the data ï‚· The immediate outcome is expected to provide a robust diagnostic tool for the detection of infection as well as guidance for treatment decisions. ï‚· Genotyping of H.pylori prevalence in our population |